Download Chapter 16 Cholinesterase Inhibitors

Drug Therapy of Rheumatoid
Arthritis
Drugs for Rheumatoid Arthritis

Rheumatoid arthritis (RA)


Autoimmune inflammatory disorder
Treatment




Relieve symptoms
Maintain joint function
Minimize systemic involvement
Delay progression of disease
Classes of Antiarthritic Drugs

NSAIDs


DMARDs


Nonsteroidal anti-inflammatory drugs
Disease-modifying antirheumatic drugs
Glucocorticoids

Adrenal corticosteroids
Drug Selection for
Rheumatoid Arthritis

Protocol



Start with NSAIDs
If symptoms persist, add DMARDs
Glucocorticoids may be added until DMARDs take
effect
DMARDs I: Major
Nonbiologic DMARDs


Methotrexate
Sulfasalazine
Methotrexate



Most rapid-acting DMARD
Therapeutic effect: 3 to 6 weeks
Adverse effects




Hepatic fibrosis
Bone marrow suppression
GI ulceration
Pneumonitis
Sulfasalazine

Used to treat inflammatory bowel disease
(IBD); now used for RA as well



Anti-inflammatory and immunomodulatory actions
Can slow progression of joint deterioration
GI side effects may be intolerable
Other DMARDs I: Major
Nonbiologic DMARDs


Leflunomid (Arava)
Hydroxychloroquine (Plaquenil)
DMARDs II: Major
Biologic DMARDs

Tumor necrosis factor inhibitors



Suppress immune function
Pose risk of serious infection
Work by neutralizing tumor necrosis factor (TNF)
• Etanercept (Enbrel)
• Infliximab (Remicade)
• Adalimumab (Humira)
Etanercept

New DMARD


Use


Inactivates TNF
Moderate to severe RA
Adverse effects






Infection (may be serious)
Injection-site reactions
Tuberculosis
Heart failure
Cancer
Other adverse effects